Physician profile
Bohan Li
NPI 1306588165
$849.49
in general payments reported to CMS, 2019-2025
10 companies · $849 in 2025
The $849 reported for 2025 was more than what 77% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $177.33 | 2025 | Physio-Stim |
| Acera Surgical, INC. | $126.92 | 2025 | Restrata Wound Matrix |
| Heron Therapeutics, INC. | $125.00 | 2025 | Zynrelef |
| Amgen INC. | $124.99 | 2025 | Repatha |
| Lifenet Health | $113.30 | 2025 | Theragenesis Wound Matrix |
| Stryker Corporation | $55.61 | 2025 | Flexband |
| Integra Lifesciences Corporation | $43.18 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axsome Therapeutics, INC. | $32.88 | 2025 | Auvelity |
| Vertex Pharmaceuticals Incorporated | $28.52 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $21.76 | 2025 | Nuedexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bohan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.